AUTHOR=Cao Zhiyu , Mai Yingren , Fang Wenli , Lei Ming , Luo Yishan , Zhao Lei , Liao Wang , Yu Qun , Xu Jiaxin , Ruan Yuting , Xiao Songhua , Mok Vincent C. T. , Shi Lin , Liu Jun ,  The Alzheimer's Disease Neuroimaging Initiative 

TITLE=The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease

JOURNAL=Frontiers in Human Neuroscience

VOLUME=16

YEAR=2022

URL=https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2022.760360

DOI=10.3389/fnhum.2022.760360

ISSN=1662-5161

ABSTRACT=<sec><title>Background</title><p>White matter hyperintensities (WMHs) and regional brain lobe atrophy coexist in the brain of patients with Alzheimer's disease (AD), but the association between them in patients with AD still lacks comprehensive investigation and solid imaging data support.</p></sec><sec><title>Objective</title><p>We explored whether WMHs can promote the pathological process of AD by aggravating atrophy in specific brain regions and tried to explain the regional specificity of these relationships.</p></sec><sec><title>Methods</title><p>A sample of 240 adults including 180 normal controls (NCs) and 80 cases with AD were drawn from the ADNI database. T1-weighted magnetic resonance imaging (MRI) and T2-weighted fluid-attenuated MRI of the participants were downloaded and were analyzed using AccuBrain<sup>®</sup> to generate the quantitative ratio of WMHs (WMHr, WMH volumes corrected by intracranial volume) and regional brain atrophy. We also divided WMHr into periventricular WMHr (PVWMHr) and deep WMHr (DWMHr) for the purpose of this study. The Cholinergic Pathways Hyperintensities Scale (CHIPS) scores were conducted by two evaluators. Independent <italic>t</italic>-test, Mann–Whitney <italic>U</italic> test, or χ<sup>2</sup> test were used to compare the demographic characteristics, and Spearman correlation coefficient values were used to determine the association between WMHs and different regions of brain atrophy.</p></sec><sec><title>Results</title><p>Positive association between WMHr and quantitative medial temporal lobe atrophy (QMTA) (<italic>r</italic><sub><italic>s</italic></sub> = 0.281, <italic>p</italic> = 0.011), temporal lobe atrophy (<italic>r</italic><sub><italic>s</italic></sub> = 0.285, <italic>p</italic> = 0.011), and insular atrophy (<italic>r</italic><sub><italic>s</italic></sub> = 0.406, <italic>p</italic> &lt; 0.001) was found in the AD group before Bonferroni correction. PVWMHr contributed to these correlations. By separately analyzing the relationship between PVWMHr and brain atrophy, we found that there were still positive correlations after correction in QMTA (<italic>r</italic><sub><italic>s</italic></sub> = 0.325, <italic>p</italic> = 0.003), temporal lobe atrophy (<italic>r</italic><sub><italic>s</italic></sub> = 0.298, <italic>p</italic> = 0.007), and insular atrophy (<italic>r</italic><sub><italic>s</italic></sub> = 0.429, <italic>p</italic> &lt; 0.001) in AD group.</p></sec><sec><title>Conclusion</title><p>WMH severity tends to be associated with regional brain atrophy in patients with AD, especially with medial temporal lobe, temporal lobe, and insular lobe atrophy. PVWMHs were devoted to these correlations.</p></sec>